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Summary To identify chromosomal loci involved in the development of proximal gastric adenocarcinoma, this study delineated the pattern of
allelic imbalance in a series of 38 adenocarcinomas arising in the gastric cardia. A total of 137 microsatellite markers covering all autosomal
arms, excluding acrocentric arms, were analysed. A mean of 35 out of a total of 39 chromosomal arms studied were informative for each
patient. The tumour group demonstrated a high level of allelic imbalance, with an observed median fractional allelic imbalance of 0.47 forthe
29 intestinal-type adenocarcinomas and 0.54 for the nine diffuse-type adenocarcinomas. Allelic imbalance was detected in >50% of
informative cases in both histological subtypes on a number of chromosomal arms. In the intestinal subtype, these included, 3p (61%), 4q
(71%), 5q (59%), 8p (60%), 9p (65%), 9q (83%), 12q (52%), 13q (52%), 17p (78%) and 18q (70%). A higher incidence of allelic imbalance
was detected on chromosome 16q in tumours of the diffuse type relative to those of the intestinal type. A more detailed mapping on
chromosomes 4q and 6q identified a number of cases with subchromosomal breakpoints. In conclusion, this analysis has indicated regions of
the genome potentially involved in the development of proximal gastric carcinomas.
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Gastric carcinoma demonstrates marked geographic variation in
incidence and is morphologically heterogeneous. The World
Health Organization classification divides tumours into tubular,
papillary, signet-ring, mucinous and poorly differentiated types
(Watanabe et al, 1990). An alternative classification includes
the intestinal and diffuse types described by Lauren (1965). In
general, carcinomas of the gastric cardia have a poorer prognosis
than those ofthe antrum and their relative incidence appears to be
increasing in some countries (Sidoni et al, 1989; Blot et al, 1991).
These biological variations may reflect different genetic
mechanisms underlying the development of proximal and distal
gastric carcinoma.
Cancer develops as the result of an accumulation of genetic
alterations that disrupt the normal processes of cell growth and
differentiation (Hartwell, 1992). Cells must undergo numerous
genetic changes to generate a solid, metastatic tumour (Nowell,
1976). Oncogene activation, combined with the loss or inactiva-
tion oftumour-suppressor genes, are key events in tumorigenesis.
Tumour-suppressor gene inactivation usually results from a muta-
tion within one copy of the gene and the subsequent loss of the
remaining wild-type allele. Therefore, the identification ofconsis-
tent areas of chromosomal deletion in tumour DNA may indicate
regions harbouring such genes.
The development of colorectal cancer is characterized by an
accumulation of genetic alterations including altered methylation
patterns, ras mutation, and allelic loss at 5q, 17p and 18q
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(Vogelstein etal, 1988). Chromosomes 5q, 17p and 18q harbourthe
tumour-suppressor genes APC-MCC, p53, and DCC respectively
(McBride et al, 1986; Fearon et al, 1990; Kinzler et al, 1991) and
inactivation of these genes has been demonstrated in colorectal
carcinoma (Baker et al, 1990; Fearon et al, 1990; Powell et al,
1992). In contrast, the genetic events underlying the development
of gastric cancer remain poorly characterized. Cytogenetic studies
ofgastric adenocarcinoma have reported complex karyotypes, with
multiple numerical and/or structural abnormalities (Ochi et al,
1986; Ferti-Passantonopoulou et al, 1987; Seruca et al, 1993). Loss
ofheterozygozity studies have identified anumberofchromosomal
regions that demonstrate allele loss in primary gastric tumours.
These include chromosomes lq, 3p, 5q, 7q, lIp, 12q, 13q, 17p and
18q (Motomura et al, 1988; Sano et al, 1991; Uchino et al, 1992;
Ranzani et al, 1993; Rhyu et al, 1994; Schneider et al, 1995). In the
majority of these studies, relatively few chromosomal arms have
been examined and diverse patterns of allele loss have been
reported by various groups. Differences in the environmental and
genetic backgrounds of the various populations under study may
contribute to variations in the pattern of genetic changes docu-
mented. However, these discrepancies may also reflect differences
with respect to the site of origin (cardia vs antrum), histological
subtype and stage oftumours analysed in a study.
The aim of the present study was to determine the pattern of
allelic imbalance in a homogeneous series of proximal gastric
adenocarcinomas, i.e. tumours arising in the gastric cardia. A total
of 137 polymorphic markers covering all autosomal arms,
excluding acrocentric arms, were examined. The relationship
between clinicopathological parameters and allelic imbalance was
assessed. A more detailed mapping was carried out on chromo-
somes 4q and 6q to identify chromosomal breakpoints delineating
a minimum region ofinvolvement in gastric tumorigenesis.
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MATERIALS AND METHODS
Tissue collection
Matched control and tumour tissue samples were obtained intra-
operatively from 38 patients with adenocarcinoma of the gastric
cardia. The tissue was snap-frozen in liquid nitrogen and stored at
-70° until used for DNA extraction.
Control and tumour tissues were cryostat sectioned before DNA
extraction. The control tissue was obtained from adjacent gastric
mucosa and was verified as histologically normal before DNA
extraction. Frozen tumour sections were visually assessed to deter-
mine the percentage of tumour and normal tissue present. Where
possible, microdissection of the specimen was performed and
normal tissue excised to maximize the percentage of tumour in
each specimen. Only samples demonstrating >40% tumour were
selected for analysis. A number of serial sections were obtained
for DNA extraction and a final section was examined to confirm
the percentage oftumourpresent. Inaddition, frozen sections were
reviewed by a consultant pathologist (JMS) and histologically
classified according to the procedure of Lauren (1965). Tumour
stage was assessed using The American Joint Committee on
Cancer (AJCC) and The International Union against Cancer
(UICC) criteria for pathological staging (Hermanek and Sobin,
1987; Beahrs et al, 1988).
DNA extraction and microsatellite analysis
A total of 137 microsatellite markers covering all autosomal arms,
excluding acrocentric arms, were analysed. DNA was extracted
from matched control and tumour tissue samples and microsatel-
lite analysis was carried out, as described previously (Gleeson et
al, 1996). As it was not possible to distinguish between chromo-
somal gains and chromosomal losses, the term allelic imbalance
(AI), instead of loss of heterozygozity (LOH), was used to
describe altered allelic ratios in tumour DNA. AI was assessed by
direct visual comparison of the relative allelic ratios present in
matched normal and tumourDNAs. To ensure that the allele inten-
sities were within the linear range, multiple exposures of each
autoradiograph were carried out. Autoradiographs were indepen-
dently scored by CMG and SEHR. AT was scored ifone allele was
absent orexhibited altered signal intensity in tumour DNArelative
to the allelic ratio ofnormal DNA. A small number ofloci in this
study demonstrated microsatellite instability (Gleeson et al, 1996).
Al was not scored at loci demonstrating microsatellite instability.
To determine any associations between Al and clinicopathological
features, the data were analysed in subcategories according to
histological subtype (intestinal vs diffuse), degree of differentia-
tion (well-moderately differentiated vs poorly differentiated) and
tumour stage (II vs III). In addition to the markers outlined in
Table 1, a more detailed mapping was carried out on chromosomes
4q and 6q using the following microsatellite markers: D4S2364;
D4S243; D4S1646; D4S415; D4S171; D6S494; D6S255;
D6S1035; and D6S1027.
RESULTS
The 38 gastric adenocarcinomas were histologically classified
according to the procedure of Lauren (1965). The samples
included 29 cases ofthe intestinal type (well-differentiated (n = 6),
moderately differentiated (n = 12), poorly differentiated (n = 11))
A
Figure 1 Representative examples of allelic imbalance detected in gastric
adenocarcinoma. (A) Case no. 35: (1) D3S1763; (2) D4S2361; (3) D5S815;
(4) D6S474; (5) D9S302; (6) D12S374; (7) D14S306; (8) D18S535. (B) Case
no. 67: (1) D2S434; (2) D4S1647; (3) D5S815; (4) D6S262;(5) D12S374; (6)
D12S1052; (7) D13S173; (8) D14S306. (C) Case no. 81: (1) D2S1334; (2)
D2S434; (3) D3S1766; (4) D4S1647; (5) D9S299; (6) D12S392; (7)
D19S246; (8) D22S683. (D) Case no. 98; (1) D3S1763; (2) D4S1647; (3)
D5S820; (4) D6S1003; (5) D9S319; (6) D11S1985; (7) D12S1052; (8)
D22S683. C, control DNA; T, tumour DNA
and nine cases ofthe diffuse type. The tumourgroup comprised 11
stage II tumours and 27 stage III tumours.
Representative autoradiographs demonstrating AI at various
loci are shown in Figure 1. Apparent total loss of one allele was
evident at a number ofloci, however Al was frequently observed.
In these cases an altered ratio of allele signal intensity was
observed in the tumour DNA relative to matched control DNA.
The residual allele in the tumour sample may reflect the presence
ofcontaminating stromal cells in the tumourtissue or alternatively
a subpopulation of tumour cells may have retained both alleles.
Allelic imbalance may also represent the amplification of a
mutant allele without concomitant loss of the wild-type allele.
Furthermore, cytogenetic and flow cytometric studies have indi-
cated that gains in chromosome copy number occur frequently in
gastric adenocarcinoma (Ochi et al, 1986; Ferti-Passantonopoulou
et al, 1987; Flejou et al, 1994). Polymorphic DNA markers will
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detect any imbalance in parental chromosomes, including both
chromosomal losses and chromosomal gains. Thus, although
microsatellite analysis is a useful technique to identify AI in
tumour DNA itprovides limitedevidenceregarding theunderlying
genetic mechanisms involved.
In intestinal-type adenocarcinoma, Al was detected in > 50% of
cases on chromosomes 3p (61%), 4q (71%), 5q (59%), 8p (60%),
9p (65%), 9q (83%), 12q (52%), 13q (52%), 17p (78%), 18q
(70%), l9p (50%) and 22q (50%).
The diffuse-type adenocarcinomas demonstrated Al in > 50% of
cases on chromosomes lp (66%), lq (55%), 2p (56%), 2q (55%),
3p (55%), 4p (66%), 4q (78%), Sp (78%), Sq (56%), 6q (78%), 8p
(50%), 8q (50%), 9p (80%), 9q (78%), lOq (56%), llq (66%), 12p
(75%), 12q (78%), 13q (56%), 14q (66%), 15q (60%), 16p (60%),
16q (78%), 17p (100%), 18p (66%), 18q (62.5%), 19p (50%), 21q
(56%) and 22q (86%).
Table 1 lists the overall data obtained for each chromosomal
arm. A graphical representation of the resulting allelotype for the
29 intestinal-type adenocarcinomas and the nine diffuse-type
adenocarcinomas is shown in Figure 2. The fractional allelic
imbalance (FAI) of a tumour was defined as the number of chro-
mosomal arms on which Al was observed, divided by the number
ofchromosomal arms for which polymorphic markers were infor-
mative in the patient's control DNA. This definition is equivalent
Table 1 Polymorphic markers analysed and allelic imbalance observed at each locus in gastric adenocarcinoma
Number of arms with allelic imbalance
number of arms informative (%)
Chromosomea Marker Locus Location Intestinal type(n =29) Diffusetype(n =9)
1p GGAT2AO7
HYTM1
GATA12AO7
1q
lq ATA4E02
GATA7CO1
GATA4AO9
GATA4HO9
Mfd 52
lq
2p GAAT1A5
GATA8FO7
GATA8B11
GATA8FO3
2p
2q
GATA5GO2
052xf8
GATA4D07
GATA4G12
GATA12H1O
2q
3p 238wb12
200zal
GATA8B5
GATA6FO6
GGAT2GO3
ATC3D09
3p
3q GATA8D02
GATA4A1O
GATA3HO1
GATA14G12
GATA6G12
254vel
3q
4p 037yg1
158xc7
GATA7D01
4p
4q ATA2AO3
GATA2F11
GATA107
Mfd 258
165xcl1
GATA5BO2
D1S552
MYCL1
DlS534
D1S1589
D1S518
DlS547
D1S549
DlSi02
D2S423
D2S405
D2S406
D2S441
D2S436
D2S114
D2S1334
D2S434
D2S427
D3S1307
D3S1293
D3S1768
03S1766
D3S2406
D3S1752
D3S1769
D3S1764
D3S1763
03S1754
D3S2398
D3S1311
D4S394
D4S404
D4S1627
D4S2361
D4S1647
D4S1625
D4S1090
D4S408
D4S1652
1p
1p32
1p
1q
1q
1q
1q
1q
2p
2p
2
2
2
2q
2q
2q
2q
3pter
3p24
3p
3p
3
3p
3q13-q21
3q22-q24
3q22-q24
3q21-qter
3q
3qter
4p
4p
4p
4q
4q21-q23
4q27-q31
4q
4q
4q34-qter
4/16 (25)
7/20 (35)
7/23 (30)
10/27 (37)
4/20 (20)
3/19 (16)
4/17 (24)
6/21 (29)
4/14 (29)
9/28 (32)
3/10 (30)
2/16 (12.5)
1/20 (5)
2/19 (11)
4/28 (14)
3/19 (16)
4/22 (18)
2/14 (14)
4/17 (24)
2/14 (14)
7/25 (28)
7/24 (29)
8/19 (42)
9/19 (47)
8/20 (40)
7/17 (41)
5/18 (28)
17/28 (61)
5/18 (28)
6/19 (32)
7/16 (44)
5/15 (33)
7/20 (35)
4/13 (31)
11/28 (39)
9/18 (50)
6/23 (26)
7/21 (33)
10/26 (38)
11/19 (58)
12/19 (63)
11/18 (61)
11/24 (46)
16/25 (64)
15/23 (65)
20/28 (71)
5/7 (71)
2/5 (40)
5/8 (62.5)
6/9 (66)
4/8 (50)
2/5 (40)
2/5 (40)
4/7 (57)
4/8 (50)
5/9 (55)
5/9 (56)
1/5 (20)
2/5 (40)
1/4 (25)
5/9 (56)
4/7 (57)
2/6 (33)
4/6 (66)
4/6 (66)
3/5 (60)
5/9 (55)
2/5 (40)
2/6 (33)
4/7 (57)
4/5 (80)
4/9 (44)
3/5 (60)
5/9 (55)
1/4 (25)
3/7 (43)
3/6 (50)
3/6 (50)
1/3 (33)
2/5 (40)
4/9(44)
5/8 (62.5)
5/7 (71)
4/6 (66)
6/9 (66)
3/5 (60)
6/7 (86)
3/6 (50)
6/7 (86)
6/8 (75)
2/4 (50)
7/9(78)
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Table 1 Cont.
Number of arms with allelic imbalance
Number of arms informative (%)
Chromosomea Marker Locus Location Intestinal type(n =29) Diffusetype(n=9)
5p 028xb12
GATA3AO4
GATA5C10
5p
5q
238xa3
238xf4
GATA12GO2
184yb6
GATA3FO3
GATA6EO5
GATAllAll
164xb8
5q
6p GATA3HO5
192yf2
142xh6
6p
6q Mfd 131
GATA31
059yd6
ATAl F08
242zg5
GGAA8DO8
6q
7p
7p
7q
217yc5
GATA13G11
GATA4E04
Mfd340
GATA3FO1
GATA5DO8
GGAA9C07
GATA4H1O
224xh4
7q
8p
8p
8q
123xg5
GATA8G1O
Mfd 45
Mfd 177
248td9
8q
9p
9p
9q
158xf12
GATAl2C06
GATA7D12
GATA3DO4
GATA27
GATA4D1O
9q
lop
1Op
1Oq
207wd12
Mfd289
GATA7BO1
GGAA2F11
GATA48GO7
GGAA5D1O
lOq
D5S392
D5S807
D5S819
D5S427
D5S428
D5S815
D5S409
D5S818
D5S820
D5S1456
D5S408
D6S477
D6S285
D6S273
D6S251
D6S474
D6S262
D6S1003
D6S305
D6S503
D7S513
D7S817
D7S1830
D7S802
D7S820
D7S821
D7S1807
D7S1805
D7S550
D8S261
D8S111O
D8S88
D8S199
D8S284
D9S168
D9S319
D9S301
D9S303
D9S299
D9S302
D10S249
D10S466
D10S676
D10S677
DlOS1237
D10S1213
5pter
5p15
5p
5
5q
5q
5q21
5q21-q31
5q
5q
5q
6pter
6p
6p
6q14-q15
6q
6q
6q23
6q
6q27-qter
7p
7p
7
7
7q
7q
7q
7q
7q36-qter
8p
8p
8q11-q22
8q23-q24
8q
9p
9
9q13-q21
9q
9q
9q
1Opter
1Op
1Oq
1Oq
1Oq
1Oq
6/21 (29)
6/20 (30)
4/16 (25)
9/27(33)
7/16 (44)
9/21 (43)
11/23 (48)
2/17 (12)
7/15 (47)
6/16 (37.5)
8/18 (44)
5/15 (33)
17/29 (59)
8/15 (53)
5/11 (45)
4/16 (25)
10/24 (42)
9/23 (39)
9/21 (43)
7/19 (37)
7/19 (37)
10/18 (56)
8/19 (42)
13/29 (45)
5/18 (28)
4/15 (27)
7/25 (28)
3/16 (19)
4/13 (31)
9/22 (41)
8/22 (36)
4/18 (22)
7/20 (35)
4/13 (31)
13/28 (46)
12/18 (67)
6/19 (32)
15/25 (60)
4/20 (20)
7/18 (39)
11/16 (69)
13/28 (46)
11/17 (65)
11/17 (65)
14/21 (67)
8/17 (47)
12/21 (57)
10/17 (59)
12/21 (57)
24/29 (83)
3/15 (20)
6/19 (32)
8/24 (33)
4/16 (25)
5/17 (29)
4/16 (25)
3/15 (20)
9/28 (32)
4/7 (57)
5/7 (71)
6/8 (75)
7/9 (78)
4/6 (66)
3/6 (50)
3/5 (60)
3/5 (60)
2/6 (33)
3/5 (60)
4/6 (66)
2/7 (29)
5/9(56)
0/2 (0)
1/1 (100)
2/5 (40)
3/8 (37.5)
5/8 (62.5)
5/6 (83)
5/6 (83)
4/5 (80)
5/7 (71)
5/7 (71)
7/9(78)
1/7 (14)
2/6 (33)
2/9(22)
0/5 (0)
2/7 (29)
1/7 (14)
2/5 (40)
3/5 (60)
4/6 (66)
0/5 (0)
4/9(44)
3/5 (60)
3/7 (43)
4/8(50)
2/5 (40)
1/4 (25)
3/5 (60)
4/8(50)
4/5 (80)
4/5(80)
4/4 (100)
4/4 (100)
7/9 (78)
3/4 (75)
6/8 (75)
7/9 (78)
1/5 (20)
2/7 (29)
3/8 (37.5)
3/7 (43)
3/6 (50)
2/6 (33)
3/8 (37.5)
5/9(56)
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Table 1 Cont.
Number of arms with allelic imbalance
Number of arms informative (%)
Chromosomea Marker Locus Location Intestinal type(n = 29) Diffusetype(n =9)
lip GGAA17GO5
081za5
GATA6BO9
GGAA5CO4
lp
llq 256zb5
GGAA2C10
GATA4E01
Mfd 254
llq
12p GATA7FO9
GATAl 1H08
12p
12q
GATA5AO9
GATA3FO2
GATA26DO2
GATA30FO4
GATA4HO1
GATA13DO5
12q
13q Mfd 299
234yb8
21Ozb2
GATA6BO7
093yel
GATA7G10
261yg5
13q
14q GATA5HO4
GATA4BO4
Mfd 101
Mfd 165
14q
15q
15q
16p
16p
16q
16q
17p
072yb11
ATA3AO7
GATA7EO2
Mfd 168
GATA11C06
177xh6
pRM11GT
17p
17q
17q
18p
18p
18q
18q
19p
19p
19q
19q
Mfd 188
044xg3
GATA11A06
GATA13
GATA2A12
UT705
Mfd 232
GAAA1 B03
DllS1984
D11S904
D11S1392
D11S1985
D11S937
D11S1396
DllS1391
D11S976
D12S374
Dl2S391
Dl 2S1090
D12S375
Dl2S1052
D12S
D12S395
D12S392
Dl3S232
D13S220
Dl3S218
D13S325
D13S156
D13S317
Dl 3S173
D14S297
D14S306
D14S48
D14S51
D15S130
D16S748
D16S541
D16S398
D16S539
Dl 7S796
D17S513
D17S122
D17S579
Dl7S784
D18S542
D18S535
D18S543
Dl 9S394
D19S246
D19S601
11pter
11p13
11p13-p12
11
llq
llq
llq
11q23
12pter-p12
12p13
12
12q
12q
12q
12q23-qter
12q24-qter
13q11-q12
13q13
13q13
13q21-q22
13q
13q22-q21
13qter
14q
14q
14q
14q
15q
16p
16
16q
16qter
17p13
17p13
17p
17q
17qter
18p
18q
18q
19p
19q13
19q13
8/18 (44)
4/15 (27)
5/17 (29)
7/20 (35)
11/26 (42)
3/14 (21)
2/14 (14)
4/16 (25)
4/16 (25)
8/26 (31)
4/17 (24)
10/21 (48)
10/23 (43)
15/27 (56)
12/22 (55)
10/20 (50)
9/16 (56)
10/21 (48)
12/21 (57)
15/29 (52)
7/19 (37)
4/14 (29)
6/14 (43)
9/19 (47)
8/18 (44)
7/16 (44)
9/21 (43)
15/29 (52)
2/10 (20)
6/18 (33)
6/12 (50)
6/18 (33)
11/27 (41)
9/20 (45)
9/20 (45)
2/19 (11)
2V19 (11)
1/9 (11)
6/21 (29)
4/18 (22)
7/26 (27)
16/21 (76)
12/14 (86)
7/13 (54)
21/27 (78)
5/16 (31)
4/15 (27)
6/22 (27)
2/14 (14)
2/14 (14)
12/18 (67)
9/14 (64)
16/23 (70)
7/14 (50)
7/14 (50)
9/22 (41)
8/19 (42)
11/25 (44)
4/8 (50)
1/4 (25)
3/6 (50)
4/5 (80)
4/9(44)
5/8 (62.5)
1/4 (25)
4/8 (50)
4/7 (57)
6/9(66)
4/6 (66)
6/7 (86)
6/8(75)
6/7 (86)
6/7 (86)
7/8 (87.5)
5/6 (83)
5/5 (100)
6/8 (75)
7/9 (78)
4/8 (50)
2/6 (33)
2/5 (40)
2/5 (40)
2/4 (50)
2/6 (33)
3/7 (43)
5/9(56)
3/6 (50)
5/8 (62.5)
1/5 (20)
0/2 (0)
6/9 (66)
3/5 (60)
3/5 (60)
3/5 (60)
3/5 (60)
5/7 (71)
6/7 (86)
5/5 (100)
7/9 (78)
7/7 (100)
3/3 (100)
3/3 (100)
8/8 (100)
2/5 (40)
25(40)
4/6 (66)
4/6 (66)
4/7 (57)
5/6 (83)
5/8 (62.5)
3/6 (50)
3/6 (50)
4/8 (50)
2/5 (40)
4/9 (44)
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Table 1 Cont.
Number of arms with allelic imbalance
Number of arms informative (%)
Chromosomea Marker Locus Location Intestinal type (n = 29) Diffuse type (n =9)
20p 218yg3 D20S115 20p12 5/14 (36) 0/1 (0)
GGA7E02 D20S470 20p 7/20 (35) 2/6 (33)
20p 9/23 (39) 2/6 (33)
20q 123yf8 D20S106 20 4/19 (21) 0/5 (0)
273yh9 D20S119 20q 5/15 (33) 0/6 (0)
GATA45B10 D20S480 20q 7/14 (50) 2/7 (29)
066xh3 D20S102 20q 3/8 (37.5) 0/3 (0)
20q 10/25 (40) 2/9 (22)
21q GGAA2EO2 D21S1436 21q11 5/16 (31) 3/6 (50)
GATA8GO4 D21S1270 21q22 4/18 (22) 3/5 (60)
21q 7/25 (28) 5/9 (56)
22q GATA6FO5 D22S685 22q 10/21 (48) 2/3 (66)
GATA 1B12 D22S683 22q 10/23 (43) 5/6 (83)
22q 13/26 (50) 6/ (86)
aThe bold text indicates the overall rate of Al detected for each chromosomal arm. This was calculated as the percentage of informative patients showing allelic
imbalance at any marker mapping to that arm.
to that of fractional allele loss (FAL) defined by Vogelstein et al
(1989). Individual FAI values ranged from 0.11 to 0.97. The
median FAI value was 0.47 for the 29 cases of intestinal-type
adenocarcinoma and 0.54 for the nine cases ofdiffuse-type adeno-
carcinoma. The well-, moderately and poorly differentiated
subtypes ofintestinal-type adenocarcinoma exhibited median FAI
values of0.34, 0.49 and 0.49 respectively. Both stage II and stage
III tumours demonstrated a median FAI value of0.47.
Compared with histological subtype, a higher incidence of Al
was detected on 16q in tumours ofthe diffuse typerelative to those
ofthe intestinal type (7 out of9 vs 7 out of26; P = 0.02, Fisher's
exact test). A similar trend was observed when poorly differenti-
ated diffuse-type tumours were compared directly with poorly
differentiated intestinal-type tumours, but failed to reach statistical
significance (7 out of 9 vs 3 out of 11; P = 0.07, Fisher's exact
test). Within the intestinal-type tumour group, a number of loci
demonstrated a trend towards weak association with the degree
of tumour differentiation. Allelic imbalance on 3q was more
commonly associated with poorly differentiated tumours relative
to well-differentiated ones (7 out of 11 vs 0 out of 6; P = 0.03,
Fisher's exact test). A similar trend was evident when
well-moderately differentiated tumours were analysed as a group,
but failed to reach statistical significance (4 out of 17 vs 7 out of
11; P = 0.08, Fisher's exact test). There was a trend towards
increasing AI on lOp and lip in adenocarcinomas of the moder-
ately differentiated subtype compared with those of the well-
differentiated subtype (lOp, 7 out of 11 vs 0 out of5; 1ip, 7 out of
9 vs 1 out of 6; both P < 0.07, Fisher's exact test) and the poorly
differentiated subtype (lOp, 7 out of 11 vs 1 out of8; 1ip, 7 out of
9 vs 3 out of 11; both P < 0.075, Fisher's exact test). There was no
association between AT at a specific chromosomal locus and
tumour stage.
To map common regions of involvement on chromosomes 4q
and 6q, additional microsatellite markers were analysed on these
chromosomes. A number of cases were identified that showed
clear evidence ofchromosomal breakpoints. Six cases with break-
points on 4q give preliminary evidence for the involvement oftwo
distinct regions of 4q in gastric tumorigenesis. One region spans
an approximate 14 cM interval delineated by retention of
heterozygozity at D4S2361 (no. 44) and D4S1647 (no. 37). There
is evidence of involvement of a second locus on 4q. Retention of
heterozygozity at markers D4S1090 (no. 68) and D4S1652 (no.
98) delineate a maximal 50 cM region ofinvolvement. These data
are represented diagrammatically in Figure 3A. Five cases were
identified that showed evidence of breakpoints on chromosome
6q. The retention ofheterozygozity at D6S1003 (case no. 21) and
D6S255 (no. 101) defines a 16-cM interval commonly involved in
gastric tumorigenesis (Figure 3B). Examples of Al and retention
of heterozygozity at the chromosomal breakpoints are shown in
Figure 4.
DISCUSSION
To identify chromosomal regions implicated in the development of
proximal gastric carcinoma, this study presents the results of an
allelotype analysis carried out on a series of 38 adenocarcinomas
arising in the gastric cardia. The tumour group studied demon-
strated a high level of AI for both the intestinal (median FAI =
0.47) and the diffuse (median FAI = 0.54) histological subtypes.
These values are higher than those reported in previous studies of
gastric carcinoma (Motomura et al, 1988; Wada et al, 1988). This
difference may be attributable to a number of factors. First, the
tumours in this study consisted only of advanced-stage tumours
(stage II orIII) with no early-stage tumours (stage0 orI). Previous
studies of ovarian carcinoma have also reported high FAL values
in two series ofpredominantly advanced carcinomas (Cliby et al,
1993). Second, multiple markers were evaluated on most chromo-
somal arms and on average 35, out of a total of 39, chromosomal
arms were informative for each patient. Third, the selection of
tumour-rich regions for molecular analysis, may have facilitated a
more reliable detection ofAT than the study ofDNA from unfrac-
tionated tumours, a factor that may have contributed to the detec-
tion oflowerrates ofallele loss in some studies (Wadaet al, 1988).
Finally, adenocarcinomas of the gastric cardia were reported to
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Figure 2 Frequency of allelic imbalance by chromosomal arm, excluding acrocentrc arms, detected (A) in 29 cases of intestinal-type gastrc adenocarcinoma
and (B) in nine cases of diffuse-type gastric adenocarcinoma. Allelic imbalance for each arm was calculated as the percentage of informative patients showing
allelic imbalance of any marker mapping to that arm. The markers analysed in this study are listed in Table 1. *, p; O, q.
demonstrate higher levels ofDNA aneuploidy than those arising in
the gastric antrum (Flejou et al, 1994). The majority of tumours in
this series exhibited aneuploidy as assessed by flow cytometry
[67% (24 out of 36), unpublished data]. The detection of frequent
AI at the molecular level may partly reflect this underlying
genomic instability. Previous LOH studies of gastric carcinoma
have not documented the site of origin of the tumours and it
remains to be established if the higher levels of AI documented in
this study represent site-specific differences in the aetiology of
gastric cancer. The detection ofhigh levels ofaneuploidy and Al in
proximal gastric carcinomas suggests that inactivation of a key
gene controlling genomic stability may be an early and frequent
event in these carcinomas.
The present study documented Al on Sq in 58% (22 out of38) of
gastric adenocarcinomas. Allelic loss on Sq has been reported in
approximately 30% of gastric carcinomas (Neuman et al, 1991;
Sano etal, 1991; McKie etal, 1993; Ranzani et al, 1993; Rhyu et al,
1994). However, loss of the APC/MCC gene loci on 5q was docu-
mented in over 80% of flow-sorted, aneuploid cell populations in
gastric carcinoma, suggesting that Sq LOH may be associated with
the development of aneuploidy in these tumours (Tamura et al,
1993). Inactivation ofthe APC gene, on 5q21, has been implicated
in gastric tumorigenesis by the detection ofmutations in 7-21% of
tumours (Horii et al, 1992; Nakatsura et al, 1992). The detection of
APC gene mutations in gastric adenomas [20% (6 out of 30)]
indicates that such mutations may occur early in gastric tumour
development (Tamura et al, 1994). Deletion mapping on Sq in
well-differentiated gastric adenocarcinoma identified two
minimumregions ofdeletion, both ofwhich were distinct from the
APC gene locus (Tamura et al, 1996). These data suggest a role for
two additional putative tumour-suppressor genes on Sq in gastric
carcinoma.
Microsatellite analysis detected AI on 13q in 53% (20 out of38)
of gastric adenocarcinomas. Motomura et al (1988), reported
allelic loss at 13q in 41% (14 out of 34) of gastric adenocarci-
nomas. However, other studies documented a lower incidence of
13q allelic loss, ranging from 19% to 30% of cases (Uchino et al,
1992; Ranzani et al, 1993; Schneider et al, 1995). The involvement
of Rb gene abnormalities in gastric carcinoma has not been
reported.
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Figure 3 Deletion mapping (A) on chromosome 4q, and (B) on chromosome
6q. a The markers are listed in relative positions from the most centromeric to
the most telomeric. , Loss of heterozygozity; E1, heterozygous;
X, homozygous/not done
In this study, the majority of gastric tumours displayed Al at
either 17p or 18q or atbothloci, suggesting thatthey are commonly
involved in adenocarcinoma of the gastric cardia. Approximately
37.5-74% ofgastric carcinomas were reported to demonstrate 17p
allelic loss (Sano et al, 1991; Seruca et al, 1992; Ranzani et al,
1993; Rhyu et al, 1994; Schneider et al, 1995). Both p53 gene
mutation (Renault et al, 1993; Uchino et al, 1993; Hongyo et al,
1995) and diffuse p53 protein expression (Flejou et al, 1994;
Fukunaga et al, 1994) have been documented in gastric tumours,
suggesting thatp53 gene inactivation is the target of 17p allelic loss
inthese tumours. Schneider etal (1995) reported low levels ofAl at
the DCC-linked locus, D18S51 in gastric adenocarcinoma. Other
studies, however, have reported levels of 18q LOH ranging from
47% to 61% of tumours, occurring in both early tumours and
advanced tumours (Uchino et al, 1992; Ranzani et al, 1993).
A putative common region of deletion, including the DCC gene
locus, has been identified at 18q21.3-qter (Uchino et al, 1992).
Therefore, the present study and numerous previous reports
have implicated allelic loss at Sq, 13q, 17p and 18q in gastric
tumorigenesis. These chromosomes harbour the known tumour-
suppressor genes APC/MCC, Rb, p53 and DCC (McBride et al,
1986; Lee et al, 1987; Fearon et al, 1990; Kinzler et al, 1991). In
addition to these loci, allelic loss has been documented on other
chromosomal arms in gastric adenocarcinoma. These include lq
[50% (5 out of 10) Fey et al, 1989; 25% (4 out of 16), Sano et al,
1991], 3p [36% (15 out of41) Schneideret al, 1995], 7q [(24% (10
out of 41) Sano et al, 1991; 32% (26 out of 82) Kuniyasu et al,
1994], lip [37% (7 out of 19) Ranzani et al, 1993] and 12q [55%
(6 out of 11) Fey et al, 1989; 31% (11 out of36) Sano et al, 1991;
38% (18 out of48) Schneider etal, 1995]. This study also detected
a number of additional chromosomal loci that exhibited high
levels ofAl throughout the well-, moderately and poorly differen-
tiated subtypes of intestinal adenocarcinoma and also in diffuse
adenocarcinomas. These included 3p, 4q, 6q, 9p, 9q and 12q, and
No. 68: Het No. 68: Al No. 98: Al No. 98: Hot
D4S1090 D4S243 D4S408 D4S1652
No. 21: Hot No 21 Al No. 101 Ht
DM=00 D6S494 D6S255
Figure 4 Representative examples of loss and retention of heterozygosity at
breakpoints on 4q and 6q. C, control DNA; T, tumour DNA; Al, allelic
imbalance; Het, heterozygous
may indicate chromosomal regions containing genes that are
involved in the development of adenocarcinoma of the gastric
cardia. No associations were observed between Al on a particular
chromosomal arm and tumour stage. Weak association trends were
documented between Al on 3q, lOp, Ilp and 16q, and different
histological subtypes ofgastric carcinoma.
Ranzani et al (1993) demonstrated frequent LOH at Ilp (37%)
in gastric adenocarcinoma. Subsequent deletion mapping con-
firmed a minimum region of deletion at llpl5.5 and also identi-
fied a second region of deletion at I1 q22-q23 (Baffa et al, 1996).
The detection offrequent LOH at lIpiS is consistent with a cyto-
genetic study detailing Ilpl3-15 rearrangements in seven out of
eight cases of primary adenocarcinoma of the oesophagus and
gastric cardia (Rodriguez et al, 1990). In contrast to these observa-
tions, othercytogenetic studies failed to detect lIp rearrangements
in gastric carcinoma (Ochi et al, 1986; Seruca et al, 1993) and
some LOH studies have detected few or no lIp deletions in these
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tumours (Sano et al, 1991; Uchino et al, 1992). This study demon-
strated Al on lip in 43% (15 out of 35) of gastric adenocarci-
nomas, with a trend towards a higher incidence in moderately
differentiated tumours (seven out of nine) relative to either well-
differentiated (one out ofsix) orpoorly differentiated (3 out of 11)
tumours. These data suggest that lp allelic loss may contribute to
the development of a subset ofgastric carcinomas.
A detailed molecular analysis of the E-cadherin gene demon-
strated gene mutations in 50% (13 out of26) ofdiffuse-type carci-
nomas and 14% (one out of seven) of mixed-type carcinomas
(Becker et al, 1994). In contrast, intestinal-type carcinomas
demonstrated silent mutations in 2 out of 20 tumours, indicating
that E-cadherin gene mutations may contribute to the development
of diffusely growing gastric carcinomas (Becker et al, 1994). In
agreement with this, the present study detected a trend towards
increasing Al on 16q in diffuse-type gastric carcinomas compared
with those of the intestinal type (P = 0.02, Fisher's exact test). By
virtue of its known function and location, E-cadherin represents a
potential target ofAI on 16q.
Additional studies have suggested that allele loss at a number of
loci may be specific to the development ofparticular subtypes of
gastric carcinoma (Sano et al, 1991). One study found evidence to
suggest that LOH at lq, 5q and 7p may be associated with well-
differentiated adenocarcinoma, with LOH on lq and 7p being
associated with tumour progression to advanced carcinoma. LOH
on these chromosomes was not detected in poorly differentiated
adenocarcinoma, including both intestinal and diffuse types (Sano
etal, 1991). LOH on7q was notdetected inearly tumours, but was
evident in advanced tumours of both well- and poorly differen-
tiated subtypes, suggesting an association with tumourprogression
(Sano et al, 1991; Kuniyasu et al, 1994).
Although Sano et al (1991) reported Sq LOH only in well-
differentiated adenocarcinoma, independent studies reported no
association between Sq LOH and histological subtype (McKie et
al, 1993; Rhyu et al, 1994). Similarly, this study detected Al on Sq
in both differentiated and undifferentiated intestinal types of
gastric adenocarcinoma and also in the diffuse type. APC gene
mutations have been detected morefrequently inwell-differentiated,
intestinal tumours (Nakatsura et al, 1992), but were also reported
in undifferentiated and diffuse-type carcinomas, mainly of the
signet-ring cell type (Horii et al, 1992; Nakatsura et al, 1992). To
date, therefore, studies of gastric carcinoma have documented
weak associations (Sano etal, 1991) or no associations (Schneider
et al, 1995) between allelic loss/imbalance and tumour stage,
histological subtype, or degree of differentiation. In most studies,
the small number of tumours in each histological subtype and
the predominantly advanced stage of tumour development have
precluded the reliable identification of significant associations
between allelic loss/imbalance and various clinicopathological
parameters. These limitations also apply to the present study,
possibly explaining the lack of significant associations between
molecular alterations and clinicopathological parameters. These
limitations are attributable to the fact that most gastric carcinomas
present at an advanced stage (Allum et al, 1989), and that the rela-
tively low incidence of gastric carcinoma in Western countries
hampers theacquisition oflarge tumour series forgenetic analysis.
The sites ofAI on 4q and 6q were examined in more detail and
a subset of tumours was identified that exhibited clear evidence of
chromosomal breakpoints. Cytogenetic studies have reported
rearrangements involving 4q in both primary (Rodriguez et al,
1990) and metastatic (Cagle et al, 1989) gastric carcinoma.
Despite this, one allelotype study failed to detect frequentAl on4q
in gastric carcinoma (Schneider et al, 1995). Allelic loss at 4q has
been described relatively infrequently in human malignancies.
Buetow et al (1989) reported LOH at the albumin gene locus
(4q 1-12) in five out of five informative cases of hepatocellular
carcinoma. This was confirmed in an independent study by the
detection of allelic loss on 4q in 77% (23 out of 30) ofhepatocel-
lular carcinomas (Yeh et al, 1996). Allelic loss on 4q has also been
implicated in cervical carcinoma (Mitra et al, 1994). The mapping
of a senescence function to chromosome 4 provided evidence of a
potential tumour-suppressorgene. Introduction ofanormal chromo-
some 4 into three immortal cell lines, derived from abladdercarci-
noma, a cervical carcinoma and a glioblastoma, was shown to
result in loss of proliferation and reversal of the immortal pheno-
type (Ning et al, 1991).
A numberofcytogenetic studies have reported consistent abnor-
malities involving 6q21-6qter in gastric carcinoma (Ochi et al,
1986; Rodriguez et al, 1990; Seruca et al, 1993; Panani et al, 1995;
Rao et al, 1995), with one study documenting five tumours with a
commonly deleted region spanning 6q21-6qter (Seruca et al,
1993). A number ofLOH studies failed to detect high levels of6q
allelic loss in gastric adenocarcinoma (Sano et al, 1991; Uchino et
al, 1992). More recently, deletion mapping on 6q in gastric carci-
noma has identified two regions of deletion; one located between
D6S268 (6ql6-q21) and ARGI (6q22-q23), and a second region
distal to IFNGR1 (6q23-q24) (Queimado et al, 1995). It will be of
interest to determine if the minimum region identified in the
present study, located between D6S1003 (6q23) and D6S255
(6q24-q25), corresponds to one of those identified in the other
mapping study. Evidence in the literature suggests the presence
of a number of tumour-suppressor genes on chromosome 6q.
Frequent 6q LOH has been described in a variety oftumour types,
including breast (Orphanos et al, 1995), ovarian (Cliby et al, 1993)
and colorectal (Honchel et al, 1996) carcinoma. Microcell-medi-
ated transfer of normal chromosome 6 was reported to result in
reversion of the malignant phenotype in melanoma cell lines
(Trent et al, 1990). In agreement with the presence of a tumour-
suppressor gene on 6q, loss of chromosomal loci distal to 6q21
was associated with the immortalization of SV40-transformed
human diploid fibroblasts (Hubbard-Smith et al, 1992).
In conclusion, this study documents the pattern ofAIin a series
ofproximally located gastric adenocarcinomas. Gastric carcinoma
is a heterogeneous disease, with proximal and distal gastric
tumours displaying distinct biological and epidemiological
features (Wang et al, 1986; Blot et al, 1991). To date, LOH studies
in gastric carcinoma have reported diverse patterns of allele loss
and accurate classification with respect to site of origin, tumour
morphology and stage is vital to the elucidation of the genetic
mechanisms underlying distinct subtypes of gastric cancer. This
study provides the basis for a more detailed molecular analysis of
proximal gastric adenocarcinoma.
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